Healthcare provider profile · identity verified

Daniel W Whitley, M.D.

Allopathic & Osteopathic Physicians|Internal Medicine · CORBIN, KY · NPI 1043215874

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Daniel W Whitley, M.D. received $55.46 in general payments during 2025 across 3 reported records.

Amgen Inc. accounted for 34.3% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 4 associated products.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 74 claims for Farxiga by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 40 claims for Symbicort by this doctor in 2024.

PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 251 claims for Eliquis by this doctor in 2024.

PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Paxlovid by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$55.46

3 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Amgen Inc.	Unresolved — no canonical attribution shown	$19.03	34.3%	1	2025
AstraZeneca Pharmaceuticals LP	Unresolved — no canonical attribution shown	$19.01	34.3%	1	2025
PFIZER INC.	Unresolved — no canonical attribution shown	$17.42	31.4%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$55.46	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
TEZSPIRE Normalized: tezspire	Biological	Amgen Inc., AstraZeneca Pharmaceuticals LP	$38.04	2	2025
Source payment records 2025-05-19 · AstraZeneca Pharmaceuticals LP · $19.01 · Open Payments source 2025-05-19 · Amgen Inc. · $19.03 · Open Payments source
ABRYSVO Normalized: abrysvo	Biological	PFIZER INC.	$17.42	1	2025
Source payment records 2025-01-28 · PFIZER INC. · $17.42 · Open Payments source
COMIRNATY Normalized: comirnaty	Biological	PFIZER INC.	$17.42	1	2025
Source payment records 2025-01-28 · PFIZER INC. · $17.42 · Open Payments source
PREVNAR 20 Normalized: prevnar 20	Biological	PFIZER INC.	$17.42	1	2025
Source payment records 2025-01-28 · PFIZER INC. · $17.42 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	FARXIGA open payments reported associated product	CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362	Farxiga · 2024 Exact normalized brand match · 1 Part D row	74	18
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	SYMBICORT open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610	Symbicort · 2024 Exact normalized brand match · 1 Part D row	40	17
PFIZER INC. Exact reporting entity; no affiliate inference	2025	ELIQUIS open payments reported associated product	CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063	Eliquis · 2024 Exact normalized brand match · 1 Part D row	251	41
PFIZER INC. Exact reporting entity; no affiliate inference	2025	PAXLOVID open payments reported associated product	CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432	Paxlovid · 2024 Exact normalized brand match · 1 Part D row	11	11

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	753	153
Gabapentin	Gabapentin	714	111
Pantoprazole Sodium	Pantoprazole Sodium	701	164
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	526	72
Alprazolam	Alprazolam	506	74
Atorvastatin Calcium	Atorvastatin Calcium	505	122
Amlodipine Besylate	Amlodipine Besylate	468	123
Simvastatin	Simvastatin	444	99
Furosemide	Furosemide	387	99
Lisinopril	Lisinopril	338	83
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	321	42
Losartan Potassium	Losartan Potassium	316	68
Metoprolol Tartrate	Metoprolol Tartrate	314	59
Tamsulosin Hcl	Tamsulosin Hcl	281	66
Metformin Hcl	Metformin Hcl	252	61
Eliquis	Apixaban	251	41
Omeprazole	Omeprazole	220	53
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	205	53
Mounjaro	Tirzepatide	202	29
Lorazepam	Lorazepam	201	37
Metoprolol Succinate	Metoprolol Succinate	200	49
Trazodone Hcl	Trazodone Hcl	195	44
Dicyclomine Hcl	Dicyclomine Hcl	190	56
Tramadol Hcl	Tramadol Hcl	190	41
Azithromycin	Azithromycin	186	116
Ondansetron Hcl	Ondansetron Hcl	184	80
Donepezil Hcl	Donepezil Hcl	182	39
Rosuvastatin Calcium	Rosuvastatin Calcium	178	47
Citalopram Hbr	Citalopram Hydrobromide	174	39
Clopidogrel	Clopidogrel Bisulfate	170	37
Cefdinir	Cefdinir	163	105
Glimepiride	Glimepiride	150	35
Finasteride	Finasteride	133	30
Fluconazole	Fluconazole	131	60
Promethazine Hcl	Promethazine Hcl	131	26
Methocarbamol	Methocarbamol	129	41
Isosorbide Mononitrate Er	Isosorbide Mononitrate	128	23
Fluoxetine Hcl	Fluoxetine Hcl	125	21
Tizanidine Hcl	Tizanidine Hcl	121	26
Bisoprolol Fumarate	Bisoprolol Fumarate	119	27
Hydrochlorothiazide	Hydrochlorothiazide	119	29
Meclizine Hcl	Meclizine Hcl	119	43
Pregabalin	Pregabalin	119	16
Albuterol Sulfate Hfa	Albuterol Sulfate	115	50
Carvedilol	Carvedilol	115	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	112	32
Jardiance	Empagliflozin	111	24
Clonazepam	Clonazepam	106	15
Montelukast Sodium	Montelukast Sodium	106	30
Shingrix	Varicella-Zoster Ge/As01b/Pf	106	73
Sertraline Hcl	Sertraline Hcl	104	25
Synthroid	Levothyroxine Sodium	104	24
Duloxetine Hcl	Duloxetine Hcl	102	25
Famotidine	Famotidine	101	22
Allopurinol	Allopurinol	99	23
Meloxicam	Meloxicam	96	27
Oxycodone Hcl	Oxycodone Hcl	95	15
Potassium Chloride	Potassium Chloride	94	22
Ozempic	Semaglutide	92	24
Buspirone Hcl	Buspirone Hcl	91	23
Zolpidem Tartrate	Zolpidem Tartrate	86	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	85	66
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	85	24
Ventolin Hfa	Albuterol Sulfate	85	29
Esomeprazole Magnesium	Esomeprazole Magnesium	80	17
Bupropion Xl	Bupropion Hcl	74	15
Farxiga	Dapagliflozin Propanediol	74	18
Metoclopramide Hcl	Metoclopramide Hcl	74	13
Doxycycline Monohydrate	Doxycycline Monohydrate	73	50
Diazepam	Diazepam	71	11
Escitalopram Oxalate	Escitalopram Oxalate	71	14
Linzess	Linaclotide	71	21
Atenolol	Atenolol	70	16
Ibuprofen	Ibuprofen	70	23
Fluticasone Propionate	Fluticasone Propionate	69	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	66	16
Nitroglycerin	Nitroglycerin	66	32
Hydralazine Hcl	Hydralazine Hcl	62	18
Nystatin	Nystatin	60	38
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	57	40
Triamcinolone Acetonide	Triamcinolone Acetonide	56	23
Amoxicillin	Amoxicillin	55	35
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	55	13
Alendronate Sodium	Alendronate Sodium	54	13
Janumet Xr	Sitagliptin Phos/Metformin Hcl	54	suppressed
Spironolactone	Spironolactone	54	15
Paroxetine Hcl	Paroxetine Hcl	53	11
Pioglitazone Hcl	Pioglitazone Hcl	53	12
Trulicity	Dulaglutide	52	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	49	13
Quetiapine Fumarate	Quetiapine Fumarate	49	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	48	12
Lansoprazole	Lansoprazole	48	11
Metformin Hcl Er	Metformin Hcl	48	15
Ezetimibe	Ezetimibe	47	suppressed
Diclofenac Sodium	Diclofenac Sodium	46	13
Mirtazapine	Mirtazapine	44	11
Warfarin Sodium	Warfarin Sodium	44	suppressed
Memantine Hcl	Memantine Hcl	43	suppressed
Clonidine Hcl	Clonidine Hcl	42	13
Temazepam	Temazepam	41	suppressed
Testosterone Cypionate	Testosterone Cypionate	41	15
Bumetanide	Bumetanide	40	11
Fluocinonide	Fluocinonide	40	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	12
Symbicort	Budesonide/Formoterol Fumarate	40	17
Benazepril Hcl	Benazepril Hcl	39	suppressed
Ranolazine Er	Ranolazine	38	suppressed
Estradiol	Estradiol	37	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	36	16
Doxycycline Hyclate	Doxycycline Hyclate	35	28
Janumet	Sitagliptin Phos/Metformin Hcl	35	suppressed
Midodrine Hcl	Midodrine Hcl	34	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	suppressed
Baclofen	Baclofen	33	suppressed
Famciclovir	Famciclovir	32	12
Glipizide	Glipizide	32	suppressed
Methylprednisolone	Methylprednisolone	32	27
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	32	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Glyburide	Glyburide	30	suppressed
Hydrocortisone	Hydrocortisone	30	13
Bupropion Hcl Sr	Bupropion Hcl	28	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Propranolol Hcl	Propranolol Hcl	28	suppressed
Valsartan	Valsartan	28	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	27	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	27	suppressed
Lidocaine	Lidocaine	27	suppressed
Tresiba Flextouch U-100	Insulin Degludec	27	suppressed
Trintellix	Vortioxetine Hydrobromide	27	suppressed
Amiodarone Hcl	Amiodarone Hcl	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	26	17
Oxycontin	Oxycodone Hcl	26	suppressed
Sotalol	Sotalol Hcl	26	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	16
Cilostazol	Cilostazol	25	suppressed
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Ramipril	Ramipril	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Colchicine	Colchicine	24	11
Dexlansoprazole Dr	Dexlansoprazole	24	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	24	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Entresto	Sacubitril/Valsartan	23	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Chlorzoxazone	Chlorzoxazone	21	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Naproxen	Naproxen	21	suppressed
Topiramate	Topiramate	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	20	suppressed
Ondansetron Odt	Ondansetron	20	13
Flecainide Acetate	Flecainide Acetate	19	suppressed
Lactulose	Lactulose	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Premarin	Estrogens, Conjugated	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Divalproex Sodium	Divalproex Sodium	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Celecoxib	Celecoxib	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Prednisone	Prednisone	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	15	suppressed
Doxepin Hcl	Doxepin Hcl	15	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	15	suppressed
Levofloxacin	Levofloxacin	15	suppressed
Metronidazole	Metronidazole	15	13
Mupirocin	Mupirocin	15	suppressed
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Digoxin	Digoxin	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Megestrol Acetate	Megestrol Acetate	13	suppressed
Methadone Hcl	Methadone Hcl	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Primidone	Primidone	13	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Vascepa	Icosapent Ethyl	13	suppressed
Acebutolol Hcl	Acebutolol Hcl	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Dofetilide	Dofetilide	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Glycopyrrolate	Glycopyrrolate	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Rexulti	Brexpiprazole	12	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	12	suppressed
Xtampza Er	Oxycodone Myristate	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Dexilant	Dexlansoprazole	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Testosterone	Testosterone	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$55.46 · 3 records	Amgen Inc.	ABRYSVO, COMIRNATY, PREVNAR 20, TEZSPIRE	4	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error